Sanofi Benefits From Stockpiling In Q1, Predicts Long-Term Uplift In Supplements Demand
Sanofi benefits from coronavirus-triggered stockpiling in Q1, with Consumer Healthcare head Alan Main suggesting the pandemic may have turned more consumers into regular dietary supplement users
